The offer received bids for 1.67 crore shares as against 197.63 crore shares on offer.
Posts in category Business Standard
SG Mart allots 5.57 crore equity shares under bonus issue (23-02-2024)
Powered by Capital Market – Live News
Orchid Pharma receives USFDA approval for Enmetazobactam (23-02-2024)
Orchid Pharma has received approval by the United States Food and Drug Administration (USFDA) for its novel invention, Enmetazobactam’. This development comes in close succession to the recent recommendation for approval by the European Medicines Agency (EMA).
INR Snaps Winning Streak Amid Renewed Gains In Dollar; Muted Equities (23-02-2024)
The Indian rupee consolidated in a narrow range and depreciated by 8 paise to close at 82.93 (provisional) against the US dollar on Friday, tracking a strong American currency and muted trend in domestic equities. The dollar index that measures the greenback against a basket of currencies is renewing gains after staying subdued for the week. FOMC earlier in the week showed most FOMC officials remain wary of cutting interest rates “too quickly.” The minutes of the late-January meeting said participants acknowledged risks to achieving the Fed’s employment and inflation goals were moving into better balance, but they remained highly attentive to inflation risks. Meanwhile, the benchmark S&P/BSE Sensex ended the session down 15.44 points, or 0.02 percent, at 73,142.80 while the broader NSE Nifty index settled 4.75 points, or 0.02 percent, lower at 22,212.70. At the interbank foreign exchange market, the local unit opened at 82.87 and finally settled at 82.93 (provisional) against the
NSE SME IPO of Sadhav Shipping subscribed 1.43 times (23-02-2024)
The offer received bids for 57.78 lakh shares as against 40.18 lakh shares on offer.
Suven Pharmaceuticals’ Unit 3 & 5 clear USFDA inspection (23-02-2024)
Powered by Capital Market – Live News
Ashok Leyland invest Rs 24.95 cr in TVS Trucks (23-02-2024)
Powered by Capital Market – Live News
Software firm Trust Fintech raises Rs 5.42 cr in pre-IPO funding round (23-02-2024)
Software solutions provider firm Trust Fintech Ltd on Friday said it has raised Rs 5.42 crore in a pre-IPO funding round.
Earlier this month, the company filed preliminary papers for the Initial Public Offering (IPO) and the shares are expected to be listed on NSE Emerge in March.
The IPO will be a fresh issue of 62,82,000 equity shares.
Tejas Goenka, MD of Tally Solutions; Nitin Sathawane, Head of Business at Mphasis Canada; Ramnath Raikar, former Treasury Head at HDFC Bank and Sameer Gupte, MD at NSDL Data Management Ltd were among the investors who participated in the funding round, according to a release.
The Nagpur-headquartered company provides core banking SaaS products and fintech software solutions around ERP implementation and customised software solution development, SAP B1 and Offshore IT services for the BFSI sector.
The company intends to utilise IPO proceeds for various purposes, including for establishing a new development facility at Mihan SEZ in Nagpur, and fundi
Orchid Pharma jumps after receiving USFDA nod for Exblifep injections (23-02-2024)
Orchid Pharma rallied 5.76% to Rs 1,217.20 after the company has received an approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Exblifep(Cefepime and Enmetazobactam injections).
Nifty February futures trade at premium (23-02-2024)
HDFC Bank, ICICI Bank and Reliance Industries were the top traded contracts.